ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+2.4%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$370M
AUM Growth
+$370M
(+12%)
Cap. Flow
+$91.4M
Cap. Flow
% of AUM
24.72%
Top 10 Holdings %
Top 10 Hldgs %
53.19%
Holding
85
New
33
Increased
12
Reduced
20
Closed
17
Top Buys
| 1 |
AstraZeneca
AZN
|
$18.9M |
| 2 |
Sanofi
SNY
|
$18.5M |
| 3 |
Labcorp
LH
|
$14.6M |
| 4 |
Cencora
COR
|
$12.4M |
| 5 |
Charles River Laboratories
CRL
|
$7M |
Top Sells
| 1 |
AbbVie
ABBV
|
$19.5M |
| 2 |
Bristol-Myers Squibb
BMY
|
$12.5M |
| 3 |
Icon
ICLR
|
$12.2M |
| 4 |
Johnson & Johnson
JNJ
|
$9.46M |
| 5 |
Owens & Minor
OMI
|
$7.88M |
Sector Composition
| 1 | Healthcare | 80.71% |
| 2 | Industrials | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Veracyte
VCYT
$2.41B
| $3.6M | 0.87% |
87,343
-80,868
| -48% | -$3.33M |
|
|
ADAP
27
Adaptimmune Therapeutics
ADAP
$13.9M
| $3.37M | 0.81% |
897,579
-19,909
| -2% | -$74.7K |
|
28
Sarepta Therapeutics
SRPT
$1.98B
| $2.99M | 0.72% |
+33,191
| New | +$2.99M |
|
29
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $2.87M | 0.69% |
+244,125
| New | +$2.87M |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $2.61M | 0.63% |
+160,640
| New | +$2.61M |
|
31
Insmed
INSM
$30.3B
| $2.43M | 0.59% |
89,211
-70,692
| -44% | -$1.93M |
|
32
AdaptHealth
AHCO
$1.23B
| $2.4M | 0.58% |
97,926
-96,960
| -50% | -$2.37M |
|
33
GoodRx Holdings
GDRX
$1.49B
| $2.24M | 0.54% |
+68,599
| New | +$2.24M |
|
34
Fate Therapeutics
FATE
$115M
| $2.18M | 0.53% |
+37,325
| New | +$2.18M |
|
35
Axsome Therapeutics
AXSM
$6.09B
| $2.1M | 0.51% |
55,629
+3,581
| +7% | +$135K |
|
36
Rhythm Pharmaceuticals
RYTM
$6.75B
| $1.97M | 0.48% |
+197,462
| New | +$1.97M |
|
37
ICU Medical
ICUI
$3.06B
| $1.84M | 0.44% |
+7,766
| New | +$1.84M |
|
38
Immunic
IMUX
$79.4M
| $1.77M | 0.43% |
184,543
-905
| -0.5% | -$8.66K |
|
39
Praxis Precision Medicines
PRAX
$980M
| $1.76M | 0.43% |
89,561
-64,038
| -42% | -$1.26M |
|
40
Insulet
PODD
$24.2B
| $1.7M | 0.41% |
+6,394
| New | +$1.7M |
|
41
AtriCure
ATRC
$1.73B
| $1.69M | 0.41% |
+24,253
| New | +$1.69M |
|
42
Sutro Biopharma
STRO
$85.6M
| $1.66M | 0.4% |
+111,803
| New | +$1.66M |
|
43
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.53M | 0.37% |
+66,935
| New | +$1.53M |
|
|
ALBO
44
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $1.53M | 0.37% |
65,638
-51,690
| -44% | -$1.2M |
|
45
Heron Therapeutics
HRTX
$204M
| $1.51M | 0.36% |
+165,404
| New | +$1.51M |
|
46
Viridian Therapeutics
VRDN
$1.59B
| $1.33M | 0.32% |
+67,450
| New | +$1.33M |
|
47
Gossamer Bio
GOSS
$587M
| $1.29M | 0.31% |
+113,660
| New | +$1.29M |
|
48
Nurix Therapeutics
NRIX
$723M
| $1.26M | 0.3% |
+43,542
| New | +$1.26M |
|
|
GBT
49
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.25M | 0.3% |
+42,797
| New | +$1.25M |
|
50
DarioHealth
DRIO
$22.6M
| $1.18M | 0.28% |
90,975
-59,029
| -39% | -$765K |
|